Novel Oral Antihypertensive Gets FDA's Blessing

(MedPage Today) -- The FDA has approved aprocitentan (Tryvio), making it the first endothelin receptor antagonist for the treatment of high blood pressure (BP), Idorsia Pharmaceuticals announced on Wednesday. The once-daily oral medication is...
Source: MedPage Today Public Health - Category: American Health Source Type: news